Efficacy and safety of bosentan for pulmonary arterial hypertension in adults with congenital heart disease.
about
Long-term results of treatment with bosentan in adult Eisenmenger's syndrome patients with Down's syndrome related to congenital heart disease.Riociguat for pulmonary arterial hypertension associated with congenital heart disease.Effect of bosentan on exercise capacity and clinical worsening in patients with dual down and eisenmenger syndrome.Effect of dual pulmonary vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease: a retrospective analysis.The challenge of managing pulmonary arterial hypertension in adults with congenital heart disease.Management of patients with pulmonary arterial hypertension due to congenital heart disease: recent advances and future directions.The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease: A systematic review and meta-analysis.
P2860
Q34991800-808BA5EA-B1B9-4C45-B99B-9619DDF9C272Q36374793-A472E95D-AF06-405F-917F-485C5BA7193BQ36611236-81D17982-C74B-44AB-929A-24FE12082D1FQ36811779-DB4E5C66-BA7F-413A-88C8-684786F22BB8Q38124878-D5B47FB0-4A54-4058-82ED-1A395F1B9E71Q38608883-BCDD3039-7533-480B-8500-BE68E531B7B4Q53703751-1522DF2C-2916-48FF-ABF5-D705EEDEB3C7
P2860
Efficacy and safety of bosentan for pulmonary arterial hypertension in adults with congenital heart disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Efficacy and safety of bosenta ...... with congenital heart disease.
@en
Efficacy and safety of bosenta ...... with congenital heart disease.
@nl
type
label
Efficacy and safety of bosenta ...... with congenital heart disease.
@en
Efficacy and safety of bosenta ...... with congenital heart disease.
@nl
prefLabel
Efficacy and safety of bosenta ...... with congenital heart disease.
@en
Efficacy and safety of bosenta ...... with congenital heart disease.
@nl
P2093
P1476
Efficacy and safety of bosenta ...... with congenital heart disease
@en
P2093
Bernard Clarke
Linda Griffiths
Oliver Monfredi
P304
P356
10.1016/J.AMJCARD.2011.07.006
P407
P577
2011-09-21T00:00:00Z